• 1
    Dall'Olio, F. and Chiricolo, M. (2001) Sialyltransferases in cancer. Glycoconj J. 18, 841850.
  • 2
    Harvey, B. E., Toth, C. A., Wagner, H. E., Steele, G. D. Jr., and Thomas, P. (1992) Sialyltransferase activity and hepatic tumor growth in a nude mouse model of colorectal cancer metastases. Cancer Res. 52, 17751779.
  • 3
    Majuri, M. L., Niemela, R., Tiisala, S., Renkonen, O., and Renkonen, R. (1995) Expression function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int. J. Cancer 63, 551559.
  • 4
    Yogeeswaran, G. and Salk, P. L. (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212, 15141516.
  • 5
    Dennis, J., Waller, C., Timpl, R., and Schirrmacher, V. (1982) Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature 300, 274276.
  • 6
    Burchell, J. M., Mungul, A., and Taylor-Papadimitriou, J. (2001) O-linked glycosylation in the mammary gland: changes that occur during malignancy. J. Mammary Gland Biol. Neoplasia 6, 355364.
  • 7
    Lloyd, K. O., Burchell, J., Kudryashov, V., Yin, B. W., and Taylor-Papadimitriou, J. (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 52, 3332533334.
  • 8
    Tsuji, S., Datta, A. K., and Paulson, J. C. (1996) Systematic nomenclature for sialyltransferases. Glycobiology 7, vvii.
  • 9
    Marcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., et al. (2004) Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated Sialyl-Tn antigen. Cancer Res. 64, 70507057.
  • 10
    Patani, N., Jiang, W., and Mokbel, K. (2008) Prognostic utility of glycosyltransferase expression in breast cancer. Cancer Genomics Proteomics 6, 33340.
  • 11
    Julien, S., Adriaenssens, E., Ottenberg, K., Furlan, A., Courtand, G., et al. (2006) ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology 16, 5464.
  • 12
    Schneider, F., Kemmner, W., Haensch, W., Franke, G., Gretschel, S., et al. (2001) Overexpression of sialyltransferase CMP-sialic acid: Galbeta 1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res. 11, 46054611.
  • 13
    Xu, L. X. and Zhao, M. H. (2005) Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 68, 167172.
  • 14
    Ding, J. X., Xu, L. X., Lv, J. C., Zhao, M. H., Zhang, H., et al. (2007) Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin. Immunol. 125, 2681274.
  • 15
    Ding, J. X., Xu, L. X., Zhu, L., Lv, J. C., Zhao, M. H., et al. (2009) Activity of α2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy. Scand. J. Immunol. 69, 174180.
  • 16
    Engelman, J. A., Luo, J., and Cantley, L. C. (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606619.
  • 17
    Bellacosa, A., Kumar, C. C., Di Cristofano, A., and Testa, J. R. (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94, 2986.
  • 18
    López-Knowles, E., O'Toole, S. A., McNeil, C. M., Millar, E. K., Qiu, M. R., et al. (2010) PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int. J. Cancer 126, 11211131.
  • 19
    Aleskandarany, M. A., Rakha, E. A., Ahmed, M. A., Powe, D. G., Paish, E. C, et al. (2010) PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis. Breast Cancer Res. Treat. 122, 4553.
  • 20
    Tokunaga, E., Kimura, Y., Oki, E., Ueda, N., Futatsugi, M., et al. (2006) Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int. J. Cancer 118, 284289.
  • 21
    Chun, J. and Kim, Y. S. (2013) Platycodin D inhibits the migration, invasion and growth of MDA-MB-231 human breast cancer cell via suppression of EGFR-mediated Akt and MAPK pathways. Chem. Biol. Interact. 205, 212221.
  • 22
    Yun, J., Lv, Y. G., Yao, Q., Wang, L., Li, Y. P., et al. (2012) Wortmannin inhibits proliferation and induces apoptosis of MCF-7 breast cancer cell. Eur. J. Gynaecol. Oncol. 33, 367369.
  • 23
    Dey, N., Barwick, B. G., Moreno, C. S., Ordanic-Kodani, M., Chen, Z., et al. (2013) Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer 13, 537.
  • 24
    Yang, C., Yu, K. D., Xu, W. H., Chen, A. X., Fan, L., et al. (2013) Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer. PLoS One 11, e78901.
  • 25
    Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., et al. (2007) Me s-enchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557563.
  • 26
    Pampillo, M., Camuso, N., Taylor, J. E., Szereszewski, J. M., Ahow, M. R., et al. (2009) Regulation of GPR54 signaling by GRK2 and {beta}-arrestin. Mol. Endocrinol. 23, 20602074.
  • 27
    Ohtsubo, K. and Marth, J. D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855867.
  • 28
    Zhao, Y. F., Li, Y. P., Ma, H. Y., Dong, W. J., Zhou, H. M., et al. (2014) Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma. Mol. Cell. Proteomics 13, 520536.
  • 29
    Wang, P. H., Lee, W. L., Juang, C. M., Yang, Y. H., Lo, W. H., et al. (2005) Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol 99, 631639.
  • 30
    Lopez-Morales, D., Velazquez-Marquez, N., Valenzuela, O., Santos-Lopez, G., Reyes-Leyva, J., et al. (2009) Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest. Clin. 50, 4553.